Literature DB >> 25712789

Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features.

Hanan AlSaeid Alshenawy1.   

Abstract

Renal cell carcinoma (RCC) in which clear cells with papillary architecture are present is a difficult diagnostic challenge. The most common type, clear cell RCC, only rarely has papillary architecture. The second most common one, papillary RCC, only rarely contains clear cells. However, two recently described less-common types, clear cell papillary and Xp11 translocation RCC characteristically feature both papillary architecture and cells with clear cytoplasm. Accurate diagnosis has both prognostic and therapeutic implications. This study aims to highlight the helpful cytomorphologic and immunohistochemical features of each of these entities to enable reproducible classification. Sixty RCC cases with clear cells and papillary architecture were selected and classified according to The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia and graded according to The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma then stained for CK7, carbonic anhydrase IX (CA IX), α-methylacyl-CoA-racemase (AMACR) and TFE-3. The characteristic immunoprofile of Clear RCC is CK7-, AMACR-, CA IX+ and TFE3-, papillary RCC is CK7+, AMACR+, CAIX- and TFE3-, while for clear cell papillary RCC it is CK7+, AMACR-, CAIX+ and TFE3- and lastly Xp11translocation RCC is CK7-, AMACR+, CAIX- and TFE3+. Immunohistochemical staining for CA IX, CK7, AMACR and TFE3 comprises a concise panel for distinguishing RCC with papillary and clear pattern.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25712789     DOI: 10.1007/s12253-015-9898-7

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  17 in total

1.  Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.

Authors:  Hakan Aydin; Longwen Chen; Liang Cheng; Susan Vaziri; Huiying He; Ram Ganapathi; Brett Delahunt; Cristina Magi-Galluzzi; Ming Zhou
Journal:  Am J Surg Pathol       Date:  2010-11       Impact factor: 6.394

2.  Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study.

Authors:  Hikmat A Al-Ahmadie; Darym Alden; Samson W Fine; Anuradha Gopalan; Karim A Touijer; Paul Russo; Victor E Reuter; Satish K Tickoo
Journal:  Am J Surg Pathol       Date:  2011-07       Impact factor: 6.394

3.  Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology.

Authors:  A Rose Brannon; Scott M Haake; Kathryn E Hacker; Raj S Pruthi; Eric M Wallen; Matthew E Nielsen; W Kimryn Rathmell
Journal:  Eur Urol       Date:  2011-10-18       Impact factor: 20.096

4.  Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.

Authors:  Stephen M Rohan; Yonghong Xiao; Yupu Liang; Maria E Dudas; Hikmat A Al-Ahmadie; Samson W Fine; Anuradha Gopalan; Victor E Reuter; Marc K Rosenblum; Paul Russo; Satish K Tickoo
Journal:  Mod Pathol       Date:  2011-05-20       Impact factor: 7.842

Review 5.  Renal cell carcinoma with clear cell and papillary features.

Authors:  Hillary Ross; Guido Martignoni; Pedram Argani
Journal:  Arch Pathol Lab Med       Date:  2012-04       Impact factor: 5.534

Review 6.  Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful?

Authors:  Steven S Shen; Luan D Truong; Marina Scarpelli; Antonio Lopez-Beltran
Journal:  Arch Pathol Lab Med       Date:  2012-04       Impact factor: 5.534

7.  Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade.

Authors:  Elizabeth M Genega; Musie Ghebremichael; Robert Najarian; Yineng Fu; Yihong Wang; Pedram Argani; Chiara Grisanzio; Sabina Signoretti
Journal:  Am J Clin Pathol       Date:  2010-12       Impact factor: 2.493

Review 8.  Differential diagnosis of renal tumors with papillary architecture.

Authors:  Satish K Tickoo; Victor E Reuter
Journal:  Adv Anat Pathol       Date:  2011-03       Impact factor: 3.875

9.  Immunohistochemical marker panel differentiates between the three most common subtypes of renal cell carcinoma independent from histomorphologic criteria.

Authors:  B Walter; A Hartmann; F Hofstädter; K Junker; H Moch; S Bertz; S Denzinger; W Otto; M Gajda; C G Stoehr
Journal:  Virchows Arch       Date:  2012-02-17       Impact factor: 4.064

10.  Clear cell papillary renal cell carcinoma: a report of 15 cases including three cases of concurrent other-type renal cell carcinomas.

Authors:  Jeong Hwan Park; Cheol Lee; Ja Hee Suh; Kyung Chul Moon
Journal:  Korean J Pathol       Date:  2012-12-26
View more
  5 in total

1.  Increased Expression of TICRR Predicts Poor Clinical Outcomes: A Potential Therapeutic Target for Papillary Renal Cell Carcinoma.

Authors:  Shuang Xia; Yan Lin; Jiaqiong Lin; Xiaoyong Li; Xuexian Tan; Zena Huang
Journal:  Front Genet       Date:  2021-01-11       Impact factor: 4.599

2.  Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy.

Authors:  Xi Tian; Wen-Hao Xu; Jun-Long Wu; Hua-Lei Gan; Hong-Kai Wang; Wei-Jie Gu; Yuan-Yuan Qu; Hai-Liang Zhang; Ding-Wei Ye
Journal:  Pathol Oncol Res       Date:  2021-08-27       Impact factor: 3.201

3.  Dynamic Contrast-Enhanced CT Characterization of Xp11.2 Translocation/TFE3 Gene Fusions versus Papillary Renal Cell Carcinomas.

Authors:  Jian He; Kefeng Zhou; Bin Zhu; Gutian Zhang; Xiaogong Li; Hongqian Guo; Weidong Gan; Zhengyang Zhou; Tian Liu
Journal:  Biomed Res Int       Date:  2015-11-09       Impact factor: 3.411

4.  TGR5 expression in normal kidney and renal neoplasms.

Authors:  Chaohui Lisa Zhao; Ali Amin; Yiang Hui; Dongfang Yang; Weibiao Cao
Journal:  Diagn Pathol       Date:  2018-04-02       Impact factor: 2.644

Review 5.  Carbonic Anhydrase IX in Renal Cell Carcinoma, Implications for Disease Management.

Authors:  Jean Courcier; Alexandre de la Taille; Maya Nourieh; Ingrid Leguerney; Nathalie Lassau; Alexandre Ingels
Journal:  Int J Mol Sci       Date:  2020-09-28       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.